Spinal Fusion Lumbar denied as experimental or investigational by Cigna?

Cigna's specific coverage criteria for spinal fusion lumbar are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denied Lumbar Spinal Fusion as "Experimental" — and Why That Designation Is Contestable

Cigna's experimental or investigational denial for lumbar spinal fusion typically means their clinical policy determined that insufficient evidence supports the proposed procedure for the patient's specific clinical indication — for example, a particular surgical approach, device type, or patient population that Cigna's policy does not yet recognize as proven. These denials are substantively challenging but very much worth appealing, because independent external reviewers frequently disagree with insurer experimental classifications, and federal law gives you the right to challenge them.

## Why This Denial Is Appealable

ACA §2719 requires that clinical experimental or investigational denials be eligible for external review by an independent organization. ERISA §503 requires a full-and-fair review process. The external review window is generally approximately four months from the adverse determination notice — confirm the exact date on your EOB. Expedited review is available when the patient's condition makes the standard timeline dangerous.

Critically, independent external reviewers apply their own clinical evidence standard — not Cigna's internal clinical policy — and they overturn experimental designations at a meaningful rate, particularly when the treating surgeon can document that the procedure is supported by current peer-reviewed evidence and recognized by relevant professional societies.

## Concrete Appeal Process

1. Request Cigna's clinical policy governing spinal fusion — specifically the version in effect on the date of the denial — and identify the exact evidence standard used to classify the procedure as experimental. 2. Identify the specific indication at issue — is Cigna contesting the procedure overall, or only for your particular spinal level, diagnosis, or approach? 3. File a Level 1 internal appeal with a surgeon's clinical letter and supporting literature. 4. Escalate immediately to external review if Level 1 is upheld; external reviewers are the primary check on overbroad experimental designations. 5. File a complaint with your state insurance commissioner if the denial appears inconsistent with the standard of care for your state.

## Documentation to Gather

• Diagnosis and imaging: MRI, CT, or X-ray reports with radiologist reads, confirming the structural pathology (e.g., degenerative disc disease, spondylolisthesis, spinal stenosis with instability) that the procedure addresses.
• Conservative treatment history: A complete, dated record of all prior non-surgical treatments — physical therapy, injections, medications, bracing — with documented outcomes, demonstrating that appropriate conservative management was attempted and failed.
• Surgeon's medical necessity letter: A detailed letter explaining why this specific surgical approach is the accepted standard of care for this patient's diagnosis, citing the applicable clinical guideline organization (e.g., North American Spine Society) without asserting specific numbers.
• Clinical literature summary: A brief prepared by the surgeon or a medical professional summarizing the current peer-reviewed evidence supporting the procedure for this indication.
• Second surgical opinion: A corroborating opinion from an independent spine surgeon recommending the same procedure strengthens the appeal significantly.

## Criteria-Mapping Structure

Request Cigna's technology assessment and clinical coverage policy for the specific spinal fusion procedure. For each criterion Cigna cites as unmet (e.g., peer-reviewed evidence, guideline endorsement, proven patient population), provide the surgeon's letter and clinical documentation that directly addresses that criterion. Frame each response in terms of the patient's individual clinical facts, not general arguments about the procedure.